Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.

Standard

Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. / Cracowski, Jean-Luc; Degano, Bruno; Chabot, François; Labarère, José; Schwedhelm, Edzard; Monneret, Denis; Iuliano, Luigi; Schwebel, Carole; Chaouat, Ari; Reynaud-Gaubert, Martine; Faure, Patrice; Maas, Renke; Renversez, Jean-Charles; Cracowski, Claire; Sitbon, Olivier; Yaïci, Azzedine; Simonneau, Gerald; Humbert, Marc.

In: CHEST, Vol. 142, No. 4, 4, 2012, p. 869-876.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Cracowski, J-L, Degano, B, Chabot, F, Labarère, J, Schwedhelm, E, Monneret, D, Iuliano, L, Schwebel, C, Chaouat, A, Reynaud-Gaubert, M, Faure, P, Maas, R, Renversez, J-C, Cracowski, C, Sitbon, O, Yaïci, A, Simonneau, G & Humbert, M 2012, 'Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.', CHEST, vol. 142, no. 4, 4, pp. 869-876. <http://www.ncbi.nlm.nih.gov/pubmed/22406961?dopt=Citation>

APA

Cracowski, J-L., Degano, B., Chabot, F., Labarère, J., Schwedhelm, E., Monneret, D., Iuliano, L., Schwebel, C., Chaouat, A., Reynaud-Gaubert, M., Faure, P., Maas, R., Renversez, J-C., Cracowski, C., Sitbon, O., Yaïci, A., Simonneau, G., & Humbert, M. (2012). Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. CHEST, 142(4), 869-876. [4]. http://www.ncbi.nlm.nih.gov/pubmed/22406961?dopt=Citation

Vancouver

Cracowski J-L, Degano B, Chabot F, Labarère J, Schwedhelm E, Monneret D et al. Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension. CHEST. 2012;142(4):869-876. 4.

Bibtex

@article{b48e96d3fa134c71abb3ba91eae29eff,
title = "Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.",
abstract = "Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to determine whether biomarkers measured at initial diagnostic right-sided heart catheterization predict 3-year all-cause mortality for incident cases of PAH independently of clinical and hemodynamic parameters.",
keywords = "Humans, Male, Female, Middle Aged, Risk Factors, Prognosis, Follow-Up Studies, Retrospective Studies, Enzyme-Linked Immunosorbent Assay, Kaplan-Meier Estimate, Lipid Peroxidation, Survival Rate/trends, France/epidemiology, Gas Chromatography-Mass Spectrometry, Biological Markers/*urine, Cause of Death/trends, F2-Isoprostanes/*urine, Hypertension, Pulmonary/enzymology/*mortality, Humans, Male, Female, Middle Aged, Risk Factors, Prognosis, Follow-Up Studies, Retrospective Studies, Enzyme-Linked Immunosorbent Assay, Kaplan-Meier Estimate, Lipid Peroxidation, Survival Rate/trends, France/epidemiology, Gas Chromatography-Mass Spectrometry, Biological Markers/*urine, Cause of Death/trends, F2-Isoprostanes/*urine, Hypertension, Pulmonary/enzymology/*mortality",
author = "Jean-Luc Cracowski and Bruno Degano and Fran{\c c}ois Chabot and Jos{\'e} Labar{\`e}re and Edzard Schwedhelm and Denis Monneret and Luigi Iuliano and Carole Schwebel and Ari Chaouat and Martine Reynaud-Gaubert and Patrice Faure and Renke Maas and Jean-Charles Renversez and Claire Cracowski and Olivier Sitbon and Azzedine Ya{\"i}ci and Gerald Simonneau and Marc Humbert",
year = "2012",
language = "English",
volume = "142",
pages = "869--876",
journal = "CHEST",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

RIS

TY - JOUR

T1 - Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.

AU - Cracowski, Jean-Luc

AU - Degano, Bruno

AU - Chabot, François

AU - Labarère, José

AU - Schwedhelm, Edzard

AU - Monneret, Denis

AU - Iuliano, Luigi

AU - Schwebel, Carole

AU - Chaouat, Ari

AU - Reynaud-Gaubert, Martine

AU - Faure, Patrice

AU - Maas, Renke

AU - Renversez, Jean-Charles

AU - Cracowski, Claire

AU - Sitbon, Olivier

AU - Yaïci, Azzedine

AU - Simonneau, Gerald

AU - Humbert, Marc

PY - 2012

Y1 - 2012

N2 - Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to determine whether biomarkers measured at initial diagnostic right-sided heart catheterization predict 3-year all-cause mortality for incident cases of PAH independently of clinical and hemodynamic parameters.

AB - Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to determine whether biomarkers measured at initial diagnostic right-sided heart catheterization predict 3-year all-cause mortality for incident cases of PAH independently of clinical and hemodynamic parameters.

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Prognosis

KW - Follow-Up Studies

KW - Retrospective Studies

KW - Enzyme-Linked Immunosorbent Assay

KW - Kaplan-Meier Estimate

KW - Lipid Peroxidation

KW - Survival Rate/trends

KW - France/epidemiology

KW - Gas Chromatography-Mass Spectrometry

KW - Biological Markers/urine

KW - Cause of Death/trends

KW - F2-Isoprostanes/urine

KW - Hypertension, Pulmonary/enzymology/mortality

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Prognosis

KW - Follow-Up Studies

KW - Retrospective Studies

KW - Enzyme-Linked Immunosorbent Assay

KW - Kaplan-Meier Estimate

KW - Lipid Peroxidation

KW - Survival Rate/trends

KW - France/epidemiology

KW - Gas Chromatography-Mass Spectrometry

KW - Biological Markers/urine

KW - Cause of Death/trends

KW - F2-Isoprostanes/urine

KW - Hypertension, Pulmonary/enzymology/mortality

M3 - SCORING: Journal article

VL - 142

SP - 869

EP - 876

JO - CHEST

JF - CHEST

SN - 0012-3692

IS - 4

M1 - 4

ER -